Hvilken er prisen på Metis Techbio-p (7666)

Prisen på Metis Techbio-p (7666) er $1.88

Hva er markedsverdien på Metis Techbio-p (7666)

Markedsverdien på Metis Techbio-p (7666) er $2.22B

Metis Techbio-p (7666) Prishistorikk

Metis TechBio Co., Ltd., founded in 2020 and headquartered in Beijing, China, (previously Hangzhou Jitai Pharmaceutical Technology Co., Ltd.) specializes in the advanced research and development of AI-powered nanomaterials. The company's core mission is to facilitate the delivery and application of active agents within carbon-based life forms, operating in both the Chinese Mainland and the United States. Central to its offerings is NanoForge, a comprehensive suite of interconnected technologies that includes a novel lipid library, foundational artificial intelligence models, METiSAIAgent, cutting-edge quantum chemistry and molecular dynamics simulations, and AI-driven screening platforms. Furthermore, Metis TechBio has developed specialized platforms like AiTEM, AiLNP, and AiRNA. These tools are crucial for simulating, predicting, and interpreting interactions at the nanoscale, thereby enabling the precise design, optimization, and validation of sophisticated nanomaterials and their associated payloads. The company provides its services through a three-tiered system: a foundational dry-wet data layer supported by integrated laboratory infrastructure, a model layer featuring METiS AI foundational models, and an application layer known as METiSAgentv. Metis TechBio primarily serves a diverse clientele, including pharmaceutical companies, biotechnology firms, and medical research institutions.

År	Ytelse
Ikke nok data for de angitte datoene.

År

Ytelse

Ikke nok data for de angitte datoene.

Selskap	Aksjepris	Endring 1år%	Land
Vertex Pharmaceuticals Incorporated VRTX.US	$547.65	40.75%	US
Argenx SE ARGX.US	$1.06K	49.04%	NL
CSL Limited CSL.AX	$122.63	-12.65%	AU
Moderna, Inc. MRNA.US	$143.63	472.23%	US
Lonza Group AG LONN.SW	$765.25	7.19%	CH

Selskap

Aksjepris

Endring 1år%

Land